Is greed holding back a drug that could treat COVID-19 patients? By: MarketWatch August 06, 2020 at 14:15 PM EDT By refusing to test a promising drug for COVID-19, Gilead Sciences is accused of putting profit ahead of the public health. Read More >> Related Stocks: Gilead Sciences